🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of Tylenol, asserting the companies withheld alleged dangers that the pain reliever posed to children's brain development.

The lawsuit arrives four weeks after Former President Trump promoted an unsubstantiated connection between using Tylenol - alternatively called acetaminophen - while pregnant and autism in children.

Paxton is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the only pain reliever approved for women during pregnancy, and Kenvue, which now manufacturers it.

In a official comment, he claimed they "misled consumers by gaining financially from pain and promoting medication regardless of the dangers."

Kenvue states there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening millions to line their pockets," the attorney general, from the Republican party, stated.

The company commented that it was "very worried by the spread of false claims on the security of acetaminophen and the possible consequences that could have on the welfare of American women and children."

On its online platform, Kenvue also stated it had "consistently assessed the relevant science and there is no credible data that indicates a established connection between consuming acetaminophen and autism."

Organizations speaking for physicians and healthcare providers share this view.

ACOG has stated acetaminophen - the key substance in Tylenol - is one of the few options for women during pregnancy to treat discomfort and elevated temperature, which can present significant medical dangers if left untreated.

"In multiple decades of investigation on the utilization of paracetamol in pregnancy, not a single reputable study has definitively established that the consumption of paracetamol in any trimester of pregnancy results in neurological conditions in young ones," the association commented.

This legal action cites latest statements from the Trump administration in arguing the medication is reportedly hazardous.

In recent weeks, the former president raised alarms from public health officials when he instructed women during pregnancy to "fight like hell" not to use acetaminophen when ill.

The FDA then published an announcement that doctors should think about restricting the consumption of acetaminophen, while also mentioning that "a direct connection" between the drug and autism in young ones has not been proven.

The Health Department head RFK Jr, who manages the FDA, had vowed in spring to conduct "a massive testing and research effort" that would establish the cause of autism spectrum disorder in a limited time.

But experts warned that identifying a sole reason of autism - considered by experts to be the consequence of a complex mix of genetic and surrounding conditions - would prove challenging.

Autism is a type of permanent neurological difference and condition that impacts how individuals perceive and engage with the surroundings, and is identified using doctors' observations.

In his court filing, Paxton - a Trump ally who is running for US Senate - alleges Kenvue and J&J "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism.

This legal action attempts to require the companies "remove any commercial messaging" that states Tylenol is reliable for expectant mothers.

The court case mirrors the complaints of a group of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of acetaminophen in 2022.

The court rejected the legal action, stating studies from the family's specialists was lacking definitive proof.